Original ArticleTermination of short term melatonin treatment in children with delayed Dim Light Melatonin Onset: Effects on sleep, health, behavior problems, and parenting stress
Introduction
Sleep onset problems are common among children. Different studies report prevalence rates varying from 11% [1] to 30% [2] or even 40% [3] of school age children who have problems falling asleep. Considering the negative consequences of sleep problems on health, interpersonal relations, psychological functioning, daily activities [4], [5], and school functioning [6], [7] it is important to treat these problems.
The pineal hormone melatonin plays a central role in the synchronization of circadian rhythms, especially the sleep–wake rhythm. Its secretion is inhibited during the day, but increases at night [8]. In some children endogenous melatonin secretion is delayed, which causes them to be unable to fall asleep at an appropriate time. This delay in melatonin secretion might be associated with a Per3 polymorphism in rare cases [9]. Exogenous melatonin, if well timed and administered in the right dose, can phase-shift the melatonin and sleep–wake rhythm [10].
Although many studies have shown that melatonin treatment has direct positive effects on sleep onset and health [11], [12], [13], optimal treatment duration has not yet been established and is mostly patient dependent. Consequently, melatonin is often used for an indefinite time and patients are advised to stop every now and then to see whether sleep problems return [14], [15]. Although several studies presented results after a relatively short treatment time [11], [12], [13], information concerning discontinuation of treatment is missing. Because more knowledge about the effects of treatment discontinuation in different phases of treatment (short, medium, long) can help to find optimal times for treatment termination, we explored the effects of short term treatment. An additional reason for examining short term treatment effects is that there is a (theoretical) risk that delayed puberty onset is related to long melatonin use [16].
There is only one study [17] that examined the effects of termination of short term (3 weeks) melatonin treatment on sleep, health and behavioral variables. In this pilot study, the positive effects of melatonin disappeared almost completely after abrupt treatment discontinuation. As the abrupt discontinuation of melatonin might have diminished the effects of melatonin on sleep, in the present study we examined the effects of half-dose treatment and thereafter complete discontinuation of melatonin. An additional advantage of half-dose treatment is that we could also investigate whether a lower dose was still effective. To our knowledge, this study is the first to investigate the effects of half dose and discontinued short term melatonin treatment on children.
In addition to the chronobiotic (phase-advance) and hypnotic (sleep promoting) effect, we also examined the effects of termination of melatonin on health, behavior problems and parenting stress. Sleep, health, behavior problems and parenting stress appear strongly related [4], [5], [18], [19], [20]. Therefore, we hypothesized that melatonin treatment would not only have positive effects on sleep, but also on these other variables. We expected the positive effects on health, behavior problems and parenting stress to remain after melatonin discontinuation only in cases where the positive effects on sleep remained. The question whether behavior problems influence the effects of melatonin treatment and melatonin termination was also examined in the present study.
Section snippets
Participants
The study was conducted in the Centre for Sleep–Wake Disorders and Chronobiology in a hospital in the Netherlands. Children were referred to the hospital by their general practitioners because of their sleep onset problems. Inclusion criteria for participation were (1) age between 5 and 12 years old; (2) the child has chronic sleep onset problems defined as (a) complaints of sleep-onset problems expressed by parents and/or child, (b) occurrence on at least 4 days/week for longer than 1 year, (c)
Sleep outcomes and Dim Light Melatonin Onset
Sleep latency and sleep start means obtained from diary data are reported in Table 1. The results showed that sleep latency was significantly longer during the stop week compared to the treatment weeks. The difference between treatment and half dose treatment was not significant. The results for sleep start were somewhat different. During the half dose and the stop week children fell asleep later than during treatment (Table 2).
Results for the actometer data were in accordance with the results
Discussion
The results showed that the positive effects of melatonin on sleep disappeared when treatment was completely discontinued. Sleep start and actual sleep time deteriorated when children took a half dose. This can be explained by later bedtimes in the half dose week.
Melatonin treatment not only improved sleep, but also improved health and decreased behavior problems and parenting stress. The positive effect of melatonin on health was also found in a previous study [13]. Although we are unaware of
Conflict of interest
The ICMJE Uniform Disclosure Form for Potential Conflict of interest associated with this article can be viewed by clicking on the following link: doi:10.1016/j.sleep.2011.03.019.
The authors have no conflicts of interests regarding the project described herein.
References (31)
- et al.
Chronic insomnia and its negative consequences for health and functioning of adolescents: a 12-month prospective study
J Adolesc Health
(2008) - et al.
The joint contribution of sleep, intelligence and motivation to school performance
Pers Individ Dif
(2004) - et al.
A practical approach to circadian rhythm sleep disorders
Sleep Med Rev
(2009) - et al.
Effect of melatonin on sleep, behavior, and cognition in ADHD and chronic sleep-onset insomnia
J Am Acad Child Adolesc Psychiatry
(2007) - et al.
Melatonin improves health status and sleep in children with idiopathic chronic sleep-onset insomnia: a randomized placebo-controlled trial
J Am Acad Child Adolesc Psychiatry
(2003) - et al.
The role of actigraphy in sleep medicine
Sleep Med Rev
(2002) - et al.
Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders
Prog Neuropsychopharmacol Biol Psychiatry
(2007) - et al.
Sleep problems of school-aged children: a complementary view
Acta Paediatr
(2000) - et al.
Odds, prevalence and predictors of sleep problems in school-age normal children
J Sleep Res
(2005) - et al.
Prevalence and course of sleep problems in childhood
Sleep
(2007)